Koren, Michael J.; Smith, Dean G.; Hunninghake, Donald B.; … - In: PharmacoEconomics 14 (1998) 1, pp. 59-70
treating patients to achieve NCEP goals using 4 reductase inhibitors: atorvastatin, simvastatin, lovastatin and fluvastatin …: $US1304 to $US1648), lovastatin ($US1972; 95% CI: $US1758 to $US2186) and fluvastatin ($US1542; 95% CI: $US1384 to $US1710 … atorvastatin compared with simvastatin, lovastatin or fluvastatin. …